A101DHomo sapiens (Human)Cancer cell line

Also known as: A-101D

🤖 AI SummaryBased on 11 publications

Quick Overview

Human melanoma cell line with potential for cancer research.

Detailed Summary

The A101D cell line is a human melanoma-derived cell line that has been studied for its genetic and molecular characteristics. It is part of a collection of cancer cell lines used in research to understand tumor biology and drug responses. The cell line is noted for its expression of certain genes and its potential role in studying cancer-related mutations and therapeutic targets. Research on A101D has contributed to understanding the genetic diversity and molecular mechanisms in melanoma, particularly in the context of oncogenic pathways and drug resistance. It is also part of studies examining the role of specific genes in cancer progression and treatment outcomes.
Generated on 6/16/2025

Basic Information

Database IDCVCL_1057
SpeciesHomo sapiens (Human)
Tissue SourceLymph node[UBERON:UBERON_0000029]

Donor Information

Age56
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseMelanoma
LineageSkin
SubtypeMelanoma
OncoTree CodeMEL

DepMap Information

Source TypeATCC
Source IDACH-000008_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTERTc.1-124C>T (c.228C>T) (C228T)UnspecifiedIn promoterfrom parent cell line Hep-G2
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D13S317
11,12
D16S539
12
D18S51
13,17
D19S433
14,14.2
D21S11
30
D2S1338
17,24
D3S1358
16
D5S818
12
D7S820
10
D8S1179
14
FGA
23,24
Penta D
13
Penta E
7,10
TH01
8,9.3
TPOX
8,11
vWA
16,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Human tumor cell strains defective in the repair of alkylation damage.

Mattern M.R.

Carcinogenesis 1:21-32(1980).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Mutations of the BRAF gene in human cancer.";

Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.

Nature 417:949-954(2002).

A molecular approach to the identification and individualization of human and animal cells in culture: isozyme and allozyme genetic signatures.

O'Brien S.J., Shannon J.E., Gail M.H.

In Vitro 16:119-135(1980).

Differential expression of the amv gene in human hematopoietic cells.

Aaronson S.A., Wong-Staal F.

Proc. Natl. Acad. Sci. U.S.A. 79:2194-2198(1982).

Repair of O6-methylguanine in DNA by demethylation is lacking in Mer- human tumor cell strains.

Yarosh D.B., Foote R.S., Mitra S., Day R.S. 3rd

Carcinogenesis 4:199-205(1983).

Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Fogh J., Wright W.C., Loveless J.D.

J. Natl. Cancer Inst. 58:209-214(1977).